IL197602A0 - Compositions and methods to prevent cancer with cupredoxins - Google Patents

Compositions and methods to prevent cancer with cupredoxins

Info

Publication number
IL197602A0
IL197602A0 IL197602A IL19760209A IL197602A0 IL 197602 A0 IL197602 A0 IL 197602A0 IL 197602 A IL197602 A IL 197602A IL 19760209 A IL19760209 A IL 19760209A IL 197602 A0 IL197602 A0 IL 197602A0
Authority
IL
Israel
Prior art keywords
cupredoxins
compositions
methods
prevent cancer
cancer
Prior art date
Application number
IL197602A
Other languages
English (en)
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of IL197602A0 publication Critical patent/IL197602A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/104Pseudomonadales, e.g. Pseudomonas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL197602A 2006-09-14 2009-03-15 Compositions and methods to prevent cancer with cupredoxins IL197602A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84435806P 2006-09-14 2006-09-14
PCT/US2007/078371 WO2008033987A2 (en) 2006-09-14 2007-09-13 Compositions and methods to prevent cancer with cupredoxins

Publications (1)

Publication Number Publication Date
IL197602A0 true IL197602A0 (en) 2011-08-01

Family

ID=39184582

Family Applications (1)

Application Number Title Priority Date Filing Date
IL197602A IL197602A0 (en) 2006-09-14 2009-03-15 Compositions and methods to prevent cancer with cupredoxins

Country Status (13)

Country Link
EP (1) EP2061498A4 (enExample)
JP (2) JP2010503409A (enExample)
KR (1) KR20090059152A (enExample)
CN (1) CN101595124A (enExample)
AU (1) AU2007296429A1 (enExample)
BR (1) BRPI0714987A2 (enExample)
CA (1) CA2663498A1 (enExample)
IL (1) IL197602A0 (enExample)
MX (1) MX2009002787A (enExample)
NO (1) NO20091267L (enExample)
RU (1) RU2009113812A (enExample)
SG (1) SG174784A1 (enExample)
WO (1) WO2008033987A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7556810B2 (en) 2005-07-19 2009-07-07 The Board Of Trustees Of The University Of Ilinois Compositions and methods to control angiogenesis with cupredoxins
US9096663B2 (en) 2001-02-15 2015-08-04 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
US7381701B2 (en) 2001-02-15 2008-06-03 The Borad Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
US10675326B2 (en) 2004-10-07 2020-06-09 The Board Of Trustees Of The University Of Illinois Compositions comprising cupredoxins for treating cancer
US9968685B2 (en) 2004-10-07 2018-05-15 Brad N. Taylor Methods to treat cancer with cupredoxins
US9598470B2 (en) * 2004-10-07 2017-03-21 Craig W. Beattie Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways
US9434770B2 (en) 2004-10-07 2016-09-06 Tapas K Das Gupta Modified cupredoxin derived peptides
AP2007003959A0 (en) 2004-10-07 2007-04-30 Ananda Chakrabarty Cupredoxin derived transport agents and methods ofuse thereof
AU2006269879A1 (en) 2005-07-19 2007-01-25 The Board Of Trustees Of The University Of Illinois Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
JP2010511408A (ja) 2006-12-04 2010-04-15 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ 癌をCpGリッチDNAおよびキュプレドキシンで治療するための組成物および方法
WO2008098216A2 (en) * 2007-02-08 2008-08-14 The Board Of Trustees Of The University Of Illinois Compositions and methods to prevent cancer with cupredoxins
US12331360B2 (en) 2017-09-29 2025-06-17 Oncgnostics Gmbh Risk determination for neoplasia and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491394B2 (en) * 2001-02-15 2009-02-17 The Board Of Trustees Of The University Of Illinois Cytotoxic factors for modulating cell death
CN1506375A (zh) * 2002-12-12 2004-06-23 浙江养生堂天然药物研究所有限公司 具有广谱抗肿瘤作用的细菌蛋白天青蛋白及其用途和含有其的药物组合物
AP2007003959A0 (en) * 2004-10-07 2007-04-30 Ananda Chakrabarty Cupredoxin derived transport agents and methods ofuse thereof
KR20080040631A (ko) * 2005-05-20 2008-05-08 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 에프린 신호전달과 관련된 질환을 쿠프레독신으로 치료하기위한 조성물과 방법
JP2009502797A (ja) * 2005-07-19 2009-01-29 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ 血管形成をキュプレドキシンで制御するための組成物および方法

Also Published As

Publication number Publication date
CA2663498A1 (en) 2008-03-20
AU2007296429A1 (en) 2008-03-20
JP2010503409A (ja) 2010-02-04
JP2014050390A (ja) 2014-03-20
RU2009113812A (ru) 2010-10-20
NO20091267L (no) 2009-06-04
MX2009002787A (es) 2009-08-27
WO2008033987A2 (en) 2008-03-20
SG174784A1 (en) 2011-10-28
WO2008033987A3 (en) 2009-04-30
KR20090059152A (ko) 2009-06-10
CN101595124A (zh) 2009-12-02
EP2061498A4 (en) 2009-11-04
EP2061498A2 (en) 2009-05-27
BRPI0714987A2 (pt) 2013-07-30

Similar Documents

Publication Publication Date Title
IL200251A0 (en) Compositions and methods to prevent cancer with cupredoxins
IL197602A0 (en) Compositions and methods to prevent cancer with cupredoxins
ZA201001300B (en) Antigen-asjuvant compositions and methods
IL210153A0 (en) Nutrigenomics methods and compositions
EP2035014A4 (en) FUCOIDANE PREPARATIONS AND METHODS
IL212822A0 (en) Anti-cxcr1 compositions and methods
EP2101731A4 (en) PROCESSES AND COMPOSITIONS WITH END OXIFES
GB0819530D0 (en) Methods and compositions
GB0721291D0 (en) Methods and compositions
EP2370815A4 (en) ANTI-INFLAMMATORY COMPOSITIONS AND RELATED METHODS
SI2061458T1 (sl) Sestavki topiramata in metode za njihovo uporabo
GB0719526D0 (en) Compositions and methods
ZA201101853B (en) Fuel compositions comprising limonane and farnesane
IL213657A0 (en) Compositions and methods to prevent cancer with cupredoxins
IL213636A0 (en) Compositions and methods to prevent cancer with cupredoxins
GB0713264D0 (en) Improvements in and relating to luminaries
IL214757A0 (en) Compositions and methods to prevent and/or treat cancer with pa-card
GB0617171D0 (en) Novel compositions and methods
ZA201000357B (en) 2-Azetidinemethaneamines and 2-pyrrolidinemethaneamines as Taar-Ligands
GB0701170D0 (en) Compositions and uses thereof
EP2061493A4 (en) COMPOSITIONS FOR REDUCING OR PREVENTING SKIN CANCER
GB0615609D0 (en) Uses and compositions comprising miRNAs
GB0701171D0 (en) Compositions and uses thereof
GB0811250D0 (en) Methods and compositions
GB0723775D0 (en) Methods and compositions